Investor Presentation
LIFE SCIENCES
Building the
Future.
Research.
Helmed by Director and Lead Scientific Advisor, Dr. Annabel Manolo-Morgan,
PhD, Flora's research arm seeks to support leading scientists and research
institutions such as Vanderbilt University and the University of Manchester to
advance access to and research of cannabinoid-based medicine.
Delivery.
Flora Life Sciences is ground zero for product innovation. Flora now has 8
patent-pending formulations, designed for use in the treatment of specific
ailments such as insomnia, epilepsy, anxiety, and pain. The revenue from
pharmaceutical and clinical-grade products can directly fund future clinical trials.
Efficacy.
Flora Life Sciences looks to identify the most efficacious combination of
plant-based compounds and derivatives to provide consumers with products
that satisfy the commitment to better living through thoughtful and curated
wellness products.
MAGISTRAL
300
MAGISTRAL
MAGISTRAL
MAGInst
NEW FORMULATIONS AVAILABLE Q4 2022
PURE
3000
MAS
AYA
A HINT OF MINT
PURE
3000 WITH THE
THU
MAS
AYA
3000 MG CBD/30mL
ZERO THC (0%)
FLORA GROWTH
11View entire presentation